2GDZ | Oxidoreductase | date | Mar 17, 2006 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of 15-Hydroxyprostaglandin Dehydrogenase T Complexed With Nad+ | ||||||||||||||
authors | E.S.Pilka, K.Guo, K.Kavanagh, F.Von Delft, C.Arrowsmith, J.Weigel A.Edwards, M.Sundstrom, U.Oppermann, Structural Genomics Conso (Sgc) | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Nad+-Dependent 15-Hydroxyprostaglandin Dehydrogen Chain: A Fragment: Residues (-1)-265 Synonym: 15 Hydroxyprostaglandin Dehydrogenase Type1 Ec: 1.1.1.141 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21-R3 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet-Sgc | ||||||||||||||
symmetry | Space Group: P 41 21 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.65 Å | ||||||||||||
ligand | NAD | enzyme | Oxidoreductase E.C.1.1.1.141 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | High-Affinity Inhibitors of Human NAD-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships., Niesen FH, Schultz L, Jadhav A, Bhatia C, Guo K, Maloney DJ, Pilka ES, Wang M, Oppermann U, Heightman TD, Simeonov A, PLoS One. 2010 Nov 2;5(11):e13719. PMID:21072165 |
Data retrieval |
View 2GDZ in 3D |
Visual 3D analysis of 2GDZ |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2GDZ |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |